BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38601687)

  • 1. Identification of a prognosis-related gene signature and ceRNA regulatory networks in lung adenocarcinoma.
    Wei H; Teng F; Wang X; Hou X; Wang H; Wang H; Sun H; Zhou X
    Heliyon; 2024 Apr; 10(7):e28084. PubMed ID: 38601687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
    Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
    Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
    Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
    J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
    Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y
    J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.
    Chen L; Ren Z; Cai Y
    Biomed Res Int; 2021; 2021():4093426. PubMed ID: 33628780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma.
    Cui Y; Cui Y; Gu R; Liu Y; Wang X; Bi L; Zhang S; Fan W; Tian F; Zhan Y; Zhang N; Xing Y; Cai L
    J Oncol; 2021; 2021():2659550. PubMed ID: 34987577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L; Zhang L
    BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma.
    Gong WJ; Zhou T; Wu SL; Huang YF; Xiang LP; Xu JQ; Han Y; Lv YN; Zeng F; Zhang Y
    Ann Transl Med; 2021 Sep; 9(18):1484. PubMed ID: 34734036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
    Li X; Li B; Ran P; Wang L
    Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
    Tang H; Wang Z; Shao Q; Wang Y; Yang Q
    Med Sci Monit; 2020 Jun; 26():e922676. PubMed ID: 32533823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
    Yang L; Ma TJ; Zhang YB; Wang H; An RH
    Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.